IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

CB Pharma Acquisition Unit

CUSIP: G2029P100 | 13 institutional holders

Quarters

Q1 2016Q4 2015Q3 2015Q2 2015Q1 2015
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q1 2016

Glazer Capital, LLC239,211
0.4% of portfolio›$2.4K
Polar Asset Management Partners Inc.200,000
0.0% of portfolio›$2.1K
Goldman Sachs Group Inc17,300
0.0% of portfolio›$176
UBS Group AG410
0.0% of portfolio›$4
Tower Research Capital LLC (TRC)64
0.0% of portfolio›$1
StyleTurnoverLocationFiled
Glazer Capital, LLC
239,211$2.4K0.4%Deep ValueVery HighNew York, NY2016-05-13
Polar Asset Management Partners Inc.
200,000$2.1K0.0%ValueVery HighToronto, Australia2016-05-16
Goldman Sachs Group Inc
17,300$1760.0%CoreMediumNew York, NY2016-05-13
UBS Group AG
410$40.0%CoreMediumZurich, Switzerland2016-05-12
Tower Research Capital LLC (TRC)
64$10.0%GARPVery HighNew York, NY2016-05-16